Literature DB >> 2915020

Recovery of Pseudomonas gladioli from respiratory tract specimens of patients with cystic fibrosis.

J C Christenson1, D F Welch, G Mukwaya, M J Muszynski, R E Weaver, D J Brenner.   

Abstract

Pseudomonas gladioli was isolated from 11 patients with cystic fibrosis. It resembled Pseudomonas cepacia on the selective and differential medium OFPBL, producing yellow colonies after 48 to 72 h of incubation. Isolates were characterized biochemically, by DNA hybridization, and by cellular fatty acid analysis. A review of the clinical status of selected patients colonized by P. gladioli did not reveal any apparent association of this organism with infectious complications of cystic fibrosis. Thus, the clinical implications may differ depending on which of these two closely related species is reported by laboratories. Determination of the fatty acid profile of isolates by gas chromatography may be a useful adjunct to biochemical characterization as a means of identification. In contrast to P. cepacia, most isolates of P. gladioli contained 3-OH C10:0 fatty acid under the growth conditions used.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2915020      PMCID: PMC267290          DOI: 10.1128/jcm.27.2.270-273.1989

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  13 in total

1.  Outbreak of hospital infection caused by contaminated autoclaved fluids.

Authors:  I Phillips; S Eykyn; M Laker
Journal:  Lancet       Date:  1972-06-10       Impact factor: 79.321

2.  A new prognostic score and clinical evaluation system for cystic fibrosis.

Authors:  L M Taussig; J Kattwinkel; W T Friedewald; P A Di Sant'Agnese
Journal:  J Pediatr       Date:  1973-03       Impact factor: 4.406

3.  Taxonomy of the aerobic pseudomonads: Pseudomonas cepacia, P. marginata, P. alliicola and P. caryophylli.

Authors:  R W Ballard; N J Palleroni; M Doudoroff; R Y Stanier; M Mandel
Journal:  J Gen Microbiol       Date:  1970-02

4.  Melioidosis.

Authors:  P Patamasucon; U B Schaad; J D Nelson
Journal:  J Pediatr       Date:  1982-02       Impact factor: 4.406

5.  Cellular fatty acid composition of selected Pseudomonas species.

Authors:  C W Moss; S B Samuels; R E Weaver
Journal:  Appl Microbiol       Date:  1972-10

6.  Selective and differential medium for recovery of Pseudomonas cepacia from the respiratory tracts of patients with cystic fibrosis.

Authors:  D F Welch; M J Muszynski; C H Pai; M J Marcon; M M Hribar; P H Gilligan; J M Matsen; P A Ahlin; B C Hilman; S A Chartrand
Journal:  J Clin Microbiol       Date:  1987-09       Impact factor: 5.948

7.  Escherichia vulneris: a new species of Enterobacteriaceae associated with human wounds.

Authors:  D J Brenner; A C McWhorter; J K Knutson; A G Steigerwalt
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

8.  Colonization of the respiratory tract with Pseudomonas cepacia in cystic fibrosis. Risk factors and outcomes.

Authors:  O C Tablan; W J Martone; C F Doershuk; R C Stern; M J Thomassen; J D Klinger; J W White; L A Carson; W R Jarvis
Journal:  Chest       Date:  1987-04       Impact factor: 9.410

9.  Laboratory proficiency test results on use of selective media for isolating Pseudomonas cepacia from simulated sputum specimens of patients with cystic fibrosis.

Authors:  O C Tablan; L A Carson; L B Cusick; L A Bland; W J Martone; W R Jarvis
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

10.  Single derivatization method for routine analysis of bacterial whole-cell fatty acid methyl esters, including hydroxy acids.

Authors:  L T Miller
Journal:  J Clin Microbiol       Date:  1982-09       Impact factor: 5.948

View more
  23 in total

1.  Evaluation of three oligonucleotide primer sets in PCR for the identification of Burkholderia cepacia and their differentiation from Burkholderia gladioli.

Authors:  F E Clode; M E Kaufmann; H Malnick; T L Pitt
Journal:  J Clin Pathol       Date:  1999-03       Impact factor: 3.411

Review 2.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 3.  Automated systems for identification of microorganisms.

Authors:  C E Stager; J R Davis
Journal:  Clin Microbiol Rev       Date:  1992-07       Impact factor: 26.132

4.  Burkholderia gladioli sepsis in newborns.

Authors:  Arzu Dursun; Aysegul Zenciroglu; Belma Saygili Karagol; Nilay Hakan; Nurullah Okumus; Nese Gol; Gonul Tanir
Journal:  Eur J Pediatr       Date:  2012-05-31       Impact factor: 3.183

5.  Identification of Burkholderia cepacia isolates from patients with cystic fibrosis and use of a simple new selective medium.

Authors:  D A Henry; M E Campbell; J J LiPuma; D P Speert
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

6.  Identification of clinical isolates of gram-negative nonfermentative bacteria by an automated cellular fatty acid identification system.

Authors:  G J Osterhout; V H Shull; J D Dick
Journal:  J Clin Microbiol       Date:  1991-09       Impact factor: 5.948

7.  Microbiological and epidemiological features of clinical respiratory isolates of Burkholderia gladioli.

Authors:  Christine Segonds; Patricia Clavel-Batut; Michelle Thouverez; Dominique Grenet; Alain Le Coustumier; Patrick Plésiat; Gérard Chabanon
Journal:  J Clin Microbiol       Date:  2009-03-18       Impact factor: 5.948

8.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

9.  Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis.

Authors:  P W Whitby; H L Dick; P W Campbell; D E Tullis; A Matlow; T L Stull
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Discrimination of Burkholderia gladioli from other Burkholderia species detectable in cystic fibrosis patients by PCR.

Authors:  A Bauernfeind; I Schneider; R Jungwirth; C Roller
Journal:  J Clin Microbiol       Date:  1998-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.